Literature DB >> 29913514

Overdose Prevention Through Medical Treatment of Opioid Use Disorders.

Nora D Volkow1, Eric M Wargo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29913514     DOI： 10.7326/M18-1397

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  18 in total

1.  Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.

Authors:  Alisa B Busch; Shelly F Greenfield; Sharon Reif; Sharon-Lise T Normand; Haiden A Huskamp
Journal:  J Subst Abuse Treat       Date:  2020-05-22

2.  Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine.

Authors:  Julia Rozanova; Sheela Shenoi; Irina Zaviryukha; Oleksandr Zeziulin; Tetiana Kiriazova; Katherine Rich; Elmira Mamedova; Volodymyr Yariy
Journal:  Subst Use Misuse       Date:  2020-07-15       Impact factor: 2.164

3.  Methylphenidate and Morphine Combination Therapy in a Rat Model of Chronic Pain.

Authors:  Zerong You; Weihua Ding; Jason T Doheny; Shiqian Shen; Jinsheng Yang; Liuyue Yang; Lucy Chen; Shengmei Zhu; Jianren Mao
Journal:  Anesth Analg       Date:  2020-02       Impact factor: 5.108

4.  U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

Authors:  Andrew I Geller; Deborah Dowell; Maribeth C Lovegrove; Jana K McAninch; Sandra K Goring; Kathleen O Rose; Nina J Weidle; Daniel S Budnitz
Journal:  Am J Prev Med       Date:  2019-03-06       Impact factor: 5.043

5.  Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use.

Authors:  Nora Jacobson; Julie Horst; Liam Wilcox-Warren; Alex Toy; Hannah K Knudsen; Randy Brown; Eric Haram; Lynn Madden; Todd Molfenter
Journal:  J Behav Health Serv Res       Date:  2020-10       Impact factor: 1.505

6.  On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.

Authors:  Sydney M Silverstein; Raminta Daniulaityte; Shannon C Miller; Silvia S Martins; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2020-03-16       Impact factor: 4.492

7.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

8.  Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.

Authors:  Erica N Onuoha; Jared A Leff; Bruce R Schackman; Kathryn E McCollister; Daniel Polsky; Sean M Murphy
Journal:  Value Health       Date:  2021-05-08       Impact factor: 5.101

Review 9.  Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.

Authors:  Amanda J Abraham; Christina M Andrews; Samantha J Harris; Peter D Friedmann
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

10.  The feasibility and safety of training patients in opioid treatment to serve as peer recovery support service interventionists.

Authors:  Frankie Kropp; Christine Wilder; Jeff Theobald; Daniel Lewis; T John Winhusen
Journal:  Subst Abus       Date:  2021-07-08       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.